Princess® RICH for the Correction of Fine Lines

Inclusion Criteria: * Subjects deemed by the treating physician to have LCL and/or PR of sufficient baseline severity to merit treatment with Princess® RICH to be corrected * A negative urine pregnancy test at Visit 1 and commitment to use an adequate method of birth control for the duration of the clinical investigation (for women of childbearing potential only.) * Healthy skin in the facial area and free of diseases that could interfere in cutaneous aging evaluation * Willingness to abstain from any aesthetic or surgical procedures in the treatment area for the duration of the clinical investigation * Written signed and dated informed consent Exclusion Criteria: * Tendency to hypertrophic scars, pigment disorders or keloid formation. * History of autoimmune disease or receiving therapy for modification of immune response * Hypersensitivity to hyaluronic acid or glycerol. * Permanent fillers in the areas to be treated. * Subjects who are pregnant or breast feeding. * Subjects who are anticoagulated or with history of bleeding disorder. * Daily treatment with platelet aggregation inhibitors unless previously cleared by their primary care physician. * Cutaneous, inflammatory and/or infectious processes present at V0, recurrent herpes simplex or (pre) cancerous lesions in the areas to be treated * Known Diabetes mellitus or uncontrolled systemic diseases in the assessment of the investigator. * Laser therapy, chemical peeling, dermabrasion or botulin toxin treatment in the area to be treated within less than three months prior to and during the course of the study. * Current participation in another clinical investigation * Subjects whose participation in clinical trials is prohibited by the Austrian Medical Devices Act (e.g, persons with a legal custodian appointed due to mental disability, prisoners, soldiers and other members of the armed forces, civil servants)